M&A Deal Summary

Analytical Lab Group Acquires Accuratus Lab Services

On August 30, 2016, Analytical Lab Group acquired medical products company Accuratus Lab Services from Ampersand Capital Partners

Acquisition Highlights
  • This is Analytical Lab Group’s 1st transaction in the Medical Products sector.
  • This is Analytical Lab Group’s 1st transaction in the United States.
  • This is Analytical Lab Group’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2016-08-30
Target Accuratus Lab Services
Sector Medical Products
Buyer(s) Analytical Lab Group
Sellers(s) Ampersand Capital Partners
Deal Type Add-on Acquisition

Target

Accuratus Lab Services

Eagan, Minnesota, United States
Accuratus Lab Services, Inc. is a provider of GMP and GLP testing services to medical device and biopharmaceutical industries to meet FDA standards, as well as EPA regulated antimicrobial and consumer products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Analytical Lab Group

Eagan, Minnesota, United States
Category Company
Founded 2006
Sector Test/Measurement Equipment
DESCRIPTION

Analytical Lab Group is an independent provider of materials and product qualification testing, inspection and certification services to the global Aerospace; Transportation & Industrials; Energy; and Fire & Building Products sectors. Analytical Lab Group was formed in 2006 and is based in Eagan, Minnesota.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 2
State (Minnesota) 1 of 1
Country (United States) 1 of 2
Year (2016) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-27 Microbiology & Quality Associates

Concord, California, United States

Microbiology & Quality Associates, Inc. is a biotechnology company offering testing laboratories, validation, calibration, and manufacturing services.

Buy -

Seller(S) 1

SELLER

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 30 of 55
Sector (Medical Products) 9 of 14
Type (Add-on Acquisition) 21 of 38
State (Minnesota) 3 of 3
Country (United States) 30 of 51
Year (2016) 8 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-22 BioClinica

Princeton, New Jersey, United States

Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific, and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serves more than 500 pharmaceutical, biotechnology, and device organizations including the top 20 biopharmaceutical companies and leading CROs through offices in North America, Europe, and Asia. Bioclinica was formed in 1990 and is based in Princeton, New Jersey.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-28 Agilux Laboratories

Worcester, Massachusetts, United States

Agilux Laboratories, Inc. is a provider of integrated discovery small and large molecule bioanalytical services, drug metabolism and pharmacokinetic (DMPK) services, and pharmacology services.

Sell $64M
Mergr

Product

Company

Legal